Lipocortin I and lipocortin II inhibit phosphoinositide- and polyphosphoinositide-specific phospholipase C The effect results from interaction with the substrates  by Machoczek, Kathrin et al.
Volume 251, number 1,2, 207-212 FEB 07395 July 1989 
Lipocortin I and lipocortin II inhibit phosphoinositide- and 
polyphosphoinositide-specific phospholipase C 
The effect results from interaction with the substrates 
Kathrin Machoczek, Manfred Fischer and Hans-Dieter Wing 
Abteilung Klin. Biochemie, Universitdt Giittingen, Robert-Koch-Str. 40, D-3400 Giittingen, FRG 
Received 30 May 1989 
Lipocortins I and II, known to inhibit phospholipase 4, have been purified from bovine lung and tested with respect 
to their ability to affect the enzymatic activities of phosphoinositide- and polyphosphoinositide-specific phospholipase 
C from human platelets, rat liver cytosol or rat brain membranes. At 0.67 FM, both lipocortins led to complete inhibition 
of phospholipase C activity with either phosphatidylinositol or phosphatidylinositol 4,5-bisphophate as substrate. The 
inhibition could be overcome by increasing the substrate concentration. Ultracentrifugation studies with lipocortin II 
showed a direct interaction between phosphatidylinositol and the lipocortin, indicating that the lipocortins inhibit phos- 
pholipase C not directly but by interacting with the substrate. In experiments with plasma membranes from PH]inositol- 
labeled HL-60 cells, lipocortin II did not affect PI-specific phospholipase C activity in the absence or presence of calcium 
plus or minus GTP-y-S. 
Calpactin; Lipocortin; Phospholipase C, polyphosphoinositide-specific 
1. INTRODUCTION 
The lipocortins represent a group of calcium- 
and phospholipid-binding proteins which have 
been implicated in the control of phospholipase A2 
[l-3]. The lipocortins belong to the calpactin 
family which is represented mainly by four pro- 
teins: (i) calpactin I (= lipocortin II), a 36 kDa 
protein serving as substrate for the pp60SarC kinase 
and protein kinase C [4-81; (ii) calpactin II 
(= lipocortin I), a 35 kDa protein serving as 
substrate for the EGF-receptor tyrosine kinase and 
protein kinase C [8-121; (iii) protein I which 
represents a tetrameric protein consisting of two 
p36 protomers and two 11 kDa proteins related to 
the S-100 protein [13]; and (iv) ~32, a 32 kDa pro- 
tein which can serve as substrate for protein kinase 
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C [6,14]. An inhibitory effect of lipocortin I was 
first described by Hirata et al. [1,2]. Davidson et 
al, [15] later showed that lipocortin II also in- 
hibited this phospholipase. More recently, Glen- 
ney’s group [16-181 reported that the inhibitory 
effect of lipocortin II results from binding of the 
lipocortin to the phospholipid substrate rather 
than from a direct effect on phospholipase A2 
itself. 
Here, we have addressed the question as to 
whether lipocortins might affect the activity of 
phosphoinositide- and polyphosphoinositide-spe- 
cific phospholipase(s) C. As these enzymes are 
directly involved in various signal transduction 
processes, their regulation by lipocortins could be 
of potential importance. 
2. MATERIALS AND METHODS 
2.1. Materials 
Phospholipase AZ from pig pancreas was obtained from 
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Sigma (Munich); DEAE-cellulose DE52 from Whatman 
(Springfield, UK); Sephadex G-100 and G-150, Sephacryl 
S-2(X)-HR, heparin-Sepharose-CL-B, phenyl-Sepharose 4B-CL, 
Mono-Q anion exchanger and Mono-S cation exchanger from 
Pharmacia (Freiburg/Brg). All chemicals were analytical grade, 
obtained from E. Merck (Darmstadt). myo-[3H]lnositol (spec. 
act. 110 Ci/mmol) and [9,10(n)-‘H]oleic acid (spec. act. 
8 Ci/mmol) were supplied by Amersham-Buchler (Braun- 
schweig). ‘H-labeled E. co/i membranes which served as 
substrate for phospholipase A2 were prepared from [3H]oleic 
acid according to Davidson et al. [lS]. [‘H]Inositol-labeled 
phosphatidylinositol was prepared by incubating 250 &i 
carrier-free [3H]inositol with 600 mg rat liver microsomal pro- 
tein and purifying [‘Hlphosphatidylinositol by thin-layer 
chromatography (TLC) as in [19]. Microsomes were prepared 
according to Takenawa and Egawa [20]. 
2.2. Methods 
2.2.1. Preparation of membranes from undifferentiated HL-60 
cells 
About 200 x lo6 undifferentiated cells were grown in Clicks 
RPM1 medium without DMSO under 5% CO2 at 37°C. Cells 
were transferred to medium 199 and incubated for 18 h in the 
presence of 1 mCi carrier-free [‘Hlinositol. Cells were subse- 
quently washed three times each with phosphate-buffered 
saline, washing buffer B (137 mM NaCl, 2.7 mM KCl, 20 mM 
Pipes, 5.6 mM glucose, 1 mg/ml of bovine serum albumin, 
1 mM myo-inositol; pH 6.8) and washing buffer C (= washing 
buffer B without myo-inositol). Membrane preparation was 
performed according to a modification of the methods of 
Stutchfield and Cockroft [21] and Hrbolich et al. [22]. 
2.2.2. Measurement of polyphosphoinositide-specific 
phospholipase C activity in membranes from HL-60 cells 
Incubation was carried out in the following medium (final 
concentrations): 25 mM Hepes, 100 mM KCl, 2.5 mM EGTA, 
1.23 mM ATP, 1.6 mM MgCl2, 10 mM LiCl; pH 7.4. The total 
volume was 220 pl. Reaction was initiated by simultaneous ad- 
dition of labeled HL-60 membranes and calcium. The total final 
concentration of calcium was 2.5 mM, and the calculated free 
Ca2+ concentration amounted to lo-’ M. When GTP-y-S was 
used, it was added to the medium prior to addition of mem- 
branes. After 10 min incubation at 37”C, the reaction was 
stopped by addition of 600 pl of 6% (w/v) trichloroacetic acid. 
Following centrifugation the supernatant was washed three 
times with diethyl ether and subsequently brought to pH 7.0 by 
titration with 1 M triethanolamine, pH 7.0. The sample was 
loaded onto a small (1.4 ml) column of Dowex 1 x 8 (200-400 
mesh) and inositol and glycerophosphoinositol were eluted with 
60 mM ammonium formate/ mM NaB&. The total 
phosphoinositols were eluted with 1.2 M ammonium for- 
mate/O.1 M formic acid and 4-ml aliquots were mixed with 
16 ml Unisolve 1, radioactivity being measured in a liquid scin- 
tillation spectrometer. 
2.2.3. Preparation of lipocortins I and II 
Fresh bovine lungs for the preparation of lipocortins were ob- 
tained from a local slaughterhouse. The first steps in this pro- 
cedure including DEAE-cellulose chromatography were 
performed according to Khanna et al. [23]. Protein fractions 
eluting between 0 and 50 mM NaCl were concentrated by 
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Amicon P-10 filtration in the presence of 20 mM Tris-Cl, 2 mM 
DTE, 1 mM EGTA and 150 mM NaCl, pH 7.4 (O’C) to 2 ml 
and applied to a Sephacryl-S 200-HR column. The first protein 
peak eluting from the column represented the p1 protein, with 
the next one corresponding to mainly lipocortin I and II. Frac- 
tions of the second peak were concentrated in the presence of 
50 mM Mes (pH 6.0) and applied to a Mono-S column. 
Lipocortin I was separated from lipocortin II by FPLC using a 
gradient from 0 to 300 mM NaCl. As lipocortin I and II did not 
clearly separate during SDS-PAGE, the identity of the peak 
containing lipocortin II was confirmed by the use of a 
monoclonal anti-lipocortin II antibody, and from the position 
of the 36 kDa protein which had been generated from the p1 
protein by treatment with 9 M urea and which eluted from the 
Mono-S column at the same ionic strength as lipocortin II. 
phospholipase(s) C
2.2.4. Preparation of polyphosphoinositide-specific 
Phospholipase C from human platelets was purified ac- 
cording to Manne and Kung [24]. The enzyme from rat liver 
cytosol was purified according to Takenawa and Nagain [19]. 
The enzyme from rat brain cortex membranes was enriched as 
described by Litosch [25]. 
Determination of the activities of phospholipase A2 and 
phospholipase C was performed as given in the legends to fig. 1 
and table 1, respectively. 
2.2.5. Binding of phosphatidylinositol to lipocortin II 
Binding was evaluated by discontinuous ucrose gradient cen- 
trifugation using a modification of the method of Davidson et 
al. 1151, except that [3H]phosphatidylinositol instead of 
radioactive phosphatidylserine was used. The final concentra- 
tion of lipocortin (as calculated for the total volume of the gra- 
dient) was 0.5 pM, that of phosphatidylinositol (in the form of 
liposomes) being 65 PM. In contrast o Davidson et al. [15], we 
did not use phosphatidylethanolamine i  addition to the labeled 
phospholipid, but employed only sonicated phosphatidylino- 
sitol. Samples (5 ml/tube) were spun on 300000 x g, in a 
Spinco SW-65 swing-out rotor for 2 h. Continuation of cen- 
trifugation for another 12 h did not significantly change the 
positions of the various compounds in the gradient. The tubes 
were punched from the bottom, 8 fractions collected from each 
tube, and the tubes analyzed for protein (by determining pro- 
tein concentration and via SDS-PAGE) and phospholipid 
radioactivity. 
3. RESULTS 
3.1. Inhibition of pancreatic phospholipase A2 
In two experiments, we investigated the effect of 
0.2 PM lipocortin I and II on pancreatic 
phospholipase AZ activity in order to monitor the 
system. Under the experimental conditions used, 
lipocortin I resulted in 94 and 89% inhibition, with 
the values for lipocortin II being 90 and 89%. 
In accordance with the findings of Davidson et 
al. [ 151, this inhibition could be suppressed by in- 
creasing substrate concentration (fig. 1). 
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Fig.1. Inhibition of pig pancreatic phospholipase AZ by 
lipocortin II (~36). The test mixture (0.4 ml) contained (final 
concentrations) 88 mM Tris-Cl, pH 7.9 (25”C), 9.6 mM CaClr, 
and 12.5 ,cl ‘H-labeled E. coli lipids which had been prepared 
according to [IS]. The reaction was started by addition of 
0.1 /cg pig pancreatic phospholipase AZ. After 5 min at 25°C 
the reaction was stopped by addition of 150~1 of 2 M HCI 
followed by 200~1 of a 10% (w/v) solution of bovine serum 
albumin in water. The mixture was vortex-mixed, spun for 
15 min at 15000 x g, and 400 ,ul of the supernatant was used for 
liquid scintillation counting. (a) Dependency of inhibition on 
the concentration of lipocortin II (~36). (b) The inhibition by 
p36 is overcome by increasing the substrate concentration. The 
reaction was performed as in (a) in the presence of 2.5 rg/ml 
(= 69 nM) ~36. The amount of labeled E. coli lipids was 
increased from 2.5 to 15 ~1. Total test volume was 0.4 ml. 
3.2. Effects on polyphosphoinositide-specific 
phospholipases C 
The effects of the two lipocortins observed with 
three different preparations of polyphosphoino- 
sitide-specific phospholipase C are presented in 
table 1. At 1.65 FM, both lipocortins completely 
abolished the cleavage of phosphatidylinositol. 
The same holds true for the cleavage of phosphati- 
dylinositol 4,5-bisphosphate (fig.2b). In ex- 
periments with phosphatidylinositol as substrate, 
inhibition could be partially overcome by in- 
creasing the substrate concentration (fig.la). Ex- 
periments with phosphatidylinositol 4,5-bisphos- 
phate were carried out over a concentration range 
where the lipocortin effect could not be sup- 
pressed. 
3.3. Interaction between phosphatidylinositol and 
lipocortin II 
The results obtained on ultracentifugation show 
that lipocortin II banded in the most heavy frac- 
tion when spun alone (fig.3a), whereas, under 
identical conditions, the phosphatidylinositol 
liposomes appeared in fractions 4 and 5 (fig.3a). 
Table 1 
Inhibition of phosphoinositide-specific phospholipase C from 
different sources by lipocortin II (~36) and lipocortin I (~35) 
Source of 
phospho- 
lipase C 
[Inhibitor] Phospholipase Inhibition 
@mol/l) C activity (o/o) 
(dpm in Ins-P) ~ 
~ Expt 1 Expt 2 
Expt 1 Expt 2 
Rat liver - 5286 6192 0 0 
1.67 ,uM p36 72 132 99 98 
Rat brain 4180 4240 0 0 
1.61pM p36 0 0 100 100 
1.66,uM ~35 0 36 100 99 
Human 5854 5320 0 0 
platelets 1.61 ctM p36 0 0 100 100 
1.66pM ~35 56 0 99 100 
Phospholipase activity was assayed over 20 min at 37°C in 
50 mM Tris-maleate, pH 6.0, containing 2 mM CaC12 and 
10 yM [‘Hlphosphatidylinositol (spec. act. about 55000 dpm/ 
nmol). The reaction was stopped by addition of 2 ml CHCW 
CHsOH/HCI (100: 100:0.6, by vol.) and the phospholipids 
extracted following addition of 0.5 ml of 1 M KCl. After phase 
separation by centrifugation, 0.5 ml of the aqueous phase were 
removed for liquid scintillation counting of radioactive inositol 
l-phosphate (Ins-P) 
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Fig.2. Inhibition of phosphoinositide-specific phospholipase C from human platelets (a) and rat brain cortex membranes (b) I 
0.67 FM lipocortin II (~36). (a) Effect of increasing concentrations of phosphatidylinositol on reaction velocity in the presence a~ 
absence of ~36. (o--O) No ~36; (M) controls without enzyme; (O--a) reaction in the presence of ~36. Note that up to 
substrate concentration of 8 PM the reaction is almost completely inhibited, but that a further increase of phosphatidylinositol restorc 
the reaction. (b) Substrate: phosphatidylinositol 4,Sbisphosphate (PIP& (M) Reaction in the absence of ~36 and (o---O) in th 
presence of ~36. Note that increasing the substrate concentration to 200 nM is insufficient for suppression of inhibition. 
When added together at a free calcium concentra- 
tion of 10 pM, the positions of both compounds 
changed and they appeared together in fraction 3 
(fig.3b). On reduction of the free calcium concen- 
tration, only a small fraction of the radioactive 
phosphatidylinositol banded together with the 
Iipocortin and the bulk of the protein was again 
recovered in the most dense fraction (fig.3c). 
3.4. Experiments with HL-60 cells 
Membranes prepared from undifferentiated 
HL-60 cells released a significant amount of la- 
beled phosphoinositols in the presence of 100 nM 
free calcium. The addition of 50pM GTP-y-S 
doubled the amount of released phosphoinositols 
(table 2). The presence of 1.5 PM Iipocortin II did 
not lead to inhibition of this effect. 
4. DISCUSSiON 
According to the present results, the inhibitory 
action of lipocortins is not restricted to the 
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phospholipase A2 reaction alone, but also affecta 
the cleavage of polyphosphoinositides by phospho- 
lipase(s) C. However, inhibition of the 
phospholipase C-catalyzed reaction seems to result 
from interaction between the lipocortins with the 
substrate phospholipid and not from direct action 
on the enzyme. This is further supported by our 
finding that the hydrolysis of phosphatidylcholine 
by phospholipase C from Bacillus cereus was not 
inhibited by Iipocortin I or II (not shown). This is 
in line with data reported by Glenney’s group, 
which show that the lipocortins interact with the 
acidic phospholipid phosphatidylserine, but not at 
all, or only very slightly with neutral phospholipids 
Ii ke phosphatidylcholine [ 151. The experiments 
with membranes from HL-60 cells also show that 
lipocortin II was unable to inhibit the membrane- 
associated polyphosphoinositide-specific phospho- 
lipase C. 
Considering the reports from Glenney’s group 
and the data presented here, it seems highly unlike- 
ly that the main physiological function of lipocor- 
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Fig.3. Calcium-dependent interaction between p36 and phosphatidylinositol during ultracentrifugation in a sucrose gradient. 
Experiments were carried out as given in section 2. In (a) p36 and [‘Hlphosphatidylinositol (PI) were run separately. In (b) the two 
components were run together in the presence of 10 ,uM [Ca*+]; in (c) the running conditions were as in (b) except that [Ca*‘] was 
lowered to <10-s M. 
tins is the regulation of phospholipase activities. 
However, as members of the calpactin family share 
the property of interacting in a calcium-dependent 
Table 2 
GTP-y-S stimulated hydrolysis of phosphoinositides in plasma 
membranes from [‘Hlinositol-prelabeled undifferentiated 
HL-60 cells: lipocortin II (~36) has no inhibitory effect 
Experimental 
conditions 
Total inositol phosphates 
released (dpm) 
Control cells 8380 
GTP-7-S (50 /rM) 19105 
plus p36 (1.5 PM) 20475 
HL-60 cells were labeled and plasma membranes equivalent o 
2.65 x lo6 dpm were incubated in the presence of lo-’ M free 
calcium as given in section 2. Total inositol phosphates 
represent he sum of inositol l-phosphate, inositol 1,4-bisphos- 
phate, inositol 1,4,5trisphosphate, inositol 1,3,4_trisphosphate 
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